The Fund supports networks of state health policy decision makers to help identify, inspire, and inform policy leaders.
The Milbank Memorial Fund supports two state leadership programs for legislative and executive branch state government officials committed to improving population health.
The Fund identifies and shares policy ideas and analysis to advance state health leadership, strong primary care, and sustainable health care costs.
Keep up with news and updates from the Milbank Memorial Fund. And read the latest blogs from our thought leaders, including Fund President Christopher F. Koller.
The Fund publishes The Milbank Quarterly, as well as reports, issues briefs, and case studies on topics important to health policy leaders.
The Milbank Memorial Fund is is a foundation that works to improve population health and health equity.
June 3, 2014
Back to Press Releases
It turns out that the history of Big Tobacco companies and marijuana is more intertwined than was previously known, according to a new study in The Milbank Quarterly. Based on previously secret tobacco industry documents, the study reveals that, since at least the 1970s, tobacco companies have been interested in marijuana as both a rival and potential product. As a result of litigation against the tobacco industry, more than 80 million pages of internal company documents became available at the University of California San Francisco’s Legacy Tobacco Documents Library (www.legacy.library.ucsf.edu). This study, led by Stanton A. Glantz, PhD, Director of the Center for Tobacco Control Research and Education at the University of California, San Francisco, is the first to systematically review these documents specifically about marijuana.
